ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

Clinical Research PA In Lung Cancer Is Released

August 16, 1991

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996

NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also

February 16, 1996

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

Toxicology Program Board To Review Nine Substances.

January 14, 2000